Opinion|Videos|January 12, 2026

Operational Challenges With Early Identification in Alzheimer Disease

Panelists discuss how APPs mitigate operational barriers that delay Alzheimer detection and diagnosis.

Panelists discuss how clinical, administrative, and systemic barriers hinder early Alzheimer identification. Limitations include inadequate screening resources, long wait times for neurology consultations, and the absence of standardized diagnostic pathways across care settings.

Panelists discuss how advanced practice providers (APPs) can help address these issues by implementing efficient workflows, establishing referral protocols, and coordinating multidisciplinary evaluations. They also advocate for better use of technology, including electronic health-record prompts and telehealth tools, to expand reach and reduce diagnostic lag.

Panelists discuss how solutions depend on organizational commitment to supporting early detection programs and empowering APPs with autonomy and training. By leading operational improvements, APPs reduce inefficiencies that contribute to delayed diagnosis and suboptimal care.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo